Transcriptomics

Dataset Information

0

B3GALT6 Promotes Dormant Breast Cancer Cell Survival and Recurrence by Enabling Heparan Sulfate-Mediated FGF Signaling


ABSTRACT: Breast cancer mortality results from incurable recurrent tumors, putatively seeded by dormant, therapy-refractory residual tumor cells (RTCs). Understanding the mechanisms enabling RTC survival is therefore essential for improving patient outcomes. We derived a dormancy-associated RTC signature that mirrors the transcriptional response to neoadjuvant chemotherapy in patients and is enriched for extracellular matrix-related pathways. In vivo CRISPR-Cas9 screening of dormancy-associated candidate genes identified the galactosyltransferase B3GALT6 as a functional regulator of RTC fitness. B3GALT6 is required for the linkage of glycosaminoglycans (GAGs) to proteins to generate proteoglycans and its germline loss-of-function causes skeletal dysplasias. We determined that B3GALT6-mediated biosynthesis of heparan sulfate GAGs predicts poor patient outcomes, promotes tumor recurrence by enhancing dormant RTC survival in multiple contexts, and does so via a B3GALT6-heparan sulfate/HS6ST1-heparan 6-O-sulfation/FGF1-FGFR2 signaling axis. These findings implicate B3GALT6 in cancer and suggest targeting of FGFR2 signaling as a novel approach to eradicate dormant RTCs, thereby preventing recurrence.

ORGANISM(S): Mus musculus

PROVIDER: GSE241252 | GEO | 2024/01/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2010-04-09 | E-GEOD-15974 | biostudies-arrayexpress
2014-11-04 | GSE51009 | GEO
2014-11-04 | E-GEOD-51009 | biostudies-arrayexpress
2022-08-09 | PXD034935 | Pride
2009-11-13 | GSE15974 | GEO
2013-05-15 | GSE46898 | GEO
2022-04-04 | PXD028931 | Pride
2021-12-18 | GSE171464 | GEO
2019-04-14 | GSE129775 | GEO
2022-01-11 | GSE193500 | GEO